In addition, IL-22 secreted by ILC3s mediates AKT signaling and promotes pancreatic cancer progression and metastasis, whereas concomitant IL-22/IL-22R or AKT blockade has also been shown to be effective 153. Here, IL22 is linked to familial pancreatic carcinoma.